Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Apr 10, 2020.

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9532-25
Dosage Form
Injection
Presentation
Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25)
Initial Posting
Apr 10, 2020

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.